"63539-502-30" National Drug Code (NDC)

Xeljanz 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30)
(U.S. Pharmaceuticals)

NDC Code63539-502-30
Package Description30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30)
Product NDC63539-502
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameXeljanz
Proprietary Name SuffixXr
Non-Proprietary NameTofacitinib
Dosage FormTABLET, EXTENDED RELEASE
UsageORAL
Start Marketing Date20200121
Marketing Category NameNDA
Application NumberNDA208246
ManufacturerU.S. Pharmaceuticals
Substance NameTOFACITINIB CITRATE
Strength22
Strength Unitmg/1
Pharmacy ClassesJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/63539-502-30